- Home
- STRS vs VTYX Comparison
STRS vs VTYX Comparison
Compare STRS & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- VTYX
- Stock Information
- Founded
- STRS 1992
- VTYX 2018
- Country
- STRS United States
- VTYX United States
- Employees
- STRS N/A
- VTYX N/A
- Industry
- STRS Homebuilding
- VTYX Medicinal Chemicals and Botanical Products
- Sector
- STRS Real Estate
- VTYX Health Care
- Exchange
- STRS Nasdaq
- VTYX Nasdaq
- Market Cap
- STRS 155.7M
- VTYX 154.9M
- IPO Year
- STRS N/A
- VTYX 2021
- Fundamental
- Price
- STRS $20.38
- VTYX $2.08
- Analyst Decision
- STRS
- VTYX Buy
- Analyst Count
- STRS 0
- VTYX 4
- Target Price
- STRS N/A
- VTYX $11.33
- AVG Volume (30 Days)
- STRS 17.7K
- VTYX 2.2M
- Earning Date
- STRS 08-12-2025
- VTYX 08-07-2025
- Dividend Yield
- STRS N/A
- VTYX N/A
- EPS Growth
- STRS N/A
- VTYX N/A
- EPS
- STRS N/A
- VTYX N/A
- Revenue
- STRS $32,719,000.00
- VTYX N/A
- Revenue This Year
- STRS N/A
- VTYX N/A
- Revenue Next Year
- STRS N/A
- VTYX N/A
- P/E Ratio
- STRS N/A
- VTYX N/A
- Revenue Growth
- STRS N/A
- VTYX N/A
- 52 Week Low
- STRS $15.10
- VTYX $0.78
- 52 Week High
- STRS $30.66
- VTYX $3.39
- Technical
- Relative Strength Index (RSI)
- STRS 59.33
- VTYX 47.92
- Support Level
- STRS $18.50
- VTYX $1.95
- Resistance Level
- STRS $19.61
- VTYX $2.51
- Average True Range (ATR)
- STRS 1.11
- VTYX 0.19
- MACD
- STRS 0.12
- VTYX -0.08
- Stochastic Oscillator
- STRS 100.00
- VTYX 19.12
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.